Celgene Corp. (CELG)

95.61
NASDAQ : Health Technology
Prev Close 93.78
Day Low/High 93.94 / 95.66
52 Wk Low/High 88.32 / 147.17
Avg Volume 6.72M
Exchange NASDAQ
Shares Outstanding 752.18M
Market Cap 70.62B
EPS 3.80
P/E Ratio 25.76
Div & Yield N.A. (N.A)

Latest News

OTEZLA® (Apremilast) Phase II Data Showed Clinically Meaningful Improvements In Patients With Active Ulcerative Colitis

OTEZLA® (Apremilast) Phase II Data Showed Clinically Meaningful Improvements In Patients With Active Ulcerative Colitis

Celgene Corporation (NASDAQ:CELG) announced that data from a randomized, placebo-controlled, multi-center, phase II clinical trial of apremilast in patients with active ulcerative colitis who had failed at least one...

Celgene Corporation Elects John Weiland To Its Board Of Directors

Celgene Corporation Elects John Weiland To Its Board Of Directors

Celgene Corporation (NASDAQ: CELG) today announced the election of John Weiland to its Board of Directors.

Three Stocks That Have My Attention

Three Stocks That Have My Attention

I continue to deploy some of the 'dry powder' into the market after its recent hiccup.

Celgene Announces Additional $5 Billion Share Repurchase Authorization

Celgene Announces Additional $5 Billion Share Repurchase Authorization

Celgene Corporation (NASDAQ: CELG) today announced the Company's Board of Directors authorized the repurchase of an additional $5 billion of the Company's common stock.

Corporate America Is Sitting on $5 Trillion of M&A Firepower

Corporate America Is Sitting on $5 Trillion of M&A Firepower

Wow. Corporate America is sitting on massive amounts of cash that could be unleashed on deals, according to new research from Citi.

Cramer: 10 Stock Surprises

Cramer: 10 Stock Surprises

In this tape, weakness may just be a sign of rest and better times to come.

Celgene Prices $4.5 Billion Of Senior Unsecured Notes

Celgene Prices $4.5 Billion Of Senior Unsecured Notes

Celgene Corporation (NASDAQ:CELG) today announced the successful pricing of four series of senior unsecured notes for an aggregate principal amount of $4.

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

A steeper fall might cause both buyers and sellers to re-think potential deals, but so far that doesn't seem to be the case yet.

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

Celgene Announces Offering Of Senior Unsecured Notes

Celgene Announces Offering Of Senior Unsecured Notes

Celgene Corporation (NASDAQ:CELG) today announced its intention to offer, subject to market and other conditions, senior unsecured notes under a shelf registration statement on Form S-3 on file with the Securities and...

Celgene Corporation Announces Positive Results From The Pivotal Phase III 'OPTIMISMM' Study Of POMALYST/IMNOVID® For The Treatment Of Relapsed Or Refractory Multiple Myeloma

Celgene Corporation Announces Positive Results From The Pivotal Phase III 'OPTIMISMM' Study Of POMALYST/IMNOVID® For The Treatment Of Relapsed Or Refractory Multiple Myeloma

Celgene Corporation (NASDAQ:CELG) today announced that the Phase III, randomized, open-label, international clinical study, OPTIMISMM, achieved its primary endpoint, showing a statistically significant and clinically...

Biotech, Pharma Stocks Tumble Amid Big Market Sell-Off

Biotech, Pharma Stocks Tumble Amid Big Market Sell-Off

Vertex Pharmaceuticals, Amgen and Johnson and Johnson were among the big movers in the biotech and pharmaceutical sectors.

Celgene Corporation Commences Tender Offer For Juno Therapeutics, Inc.

Celgene Corporation Commences Tender Offer For Juno Therapeutics, Inc.

Celgene Corporation (NASDAQ:CELG) today announced that its wholly-owned subsidiary, Blue Magpie Corporation, has commenced its previously announced tender offer for all outstanding shares of common stock of Juno...

Celgene Corporation To Webcast At Upcoming Investor Conferences

Celgene Corporation To Webcast At Upcoming Investor Conferences

Celgene Corporation (NASDAQ: CELG) plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company.

These 2 Biotech Stocks Still Have Upside

These 2 Biotech Stocks Still Have Upside

The biotech sector has seen a big rally, but there are still opportunities.

Celgene Announces Retirement Of Executive Chairman Bob Hugin And Appointment Of CEO Mark Alles As Chairman Of The Board Of Directors

Celgene Announces Retirement Of Executive Chairman Bob Hugin And Appointment Of CEO Mark Alles As Chairman Of The Board Of Directors

Celgene Corporation (NASDAQ:CELG) today announced that Executive Chairman Bob Hugin has decided to retire from Celgene after 19 years of service and to step down from the Celgene Board of Directors, effective February 5,...

Biogen, Celgene Jump on Earnings; Ford's Acquisitions Fail to Move Stock--ICYMI

Biogen, Celgene Jump on Earnings; Ford's Acquisitions Fail to Move Stock--ICYMI

Here's what you need to know now for Thursday, Jan. 25

Why 2018 Will Be Better for Biotech Deals Than 2017

Why 2018 Will Be Better for Biotech Deals Than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Celgene Says Juno, Impact Deals Won't Be Its Last

Celgene Says Juno, Impact Deals Won't Be Its Last

The biopharmaceutical giant's top executive says the company will continue to aggressively invest in R&D and deploy capital to acquire or license assets.

Davos, Caterpillar, Intel, Ford and Kroger - 5 Things You Must Know

Davos, Caterpillar, Intel, Ford and Kroger - 5 Things You Must Know

U.S. stock futures rise as the dollar plunges to a fresh three-year low. Caterpillar, Intel and 3M leading the earnings calendar.

Celgene Reports Fourth Quarter And Full-Year 2017 Operating And Financial Results

Celgene Reports Fourth Quarter And Full-Year 2017 Operating And Financial Results

Celgene Corporation (NASDAQ:CELG) reported operating results for the fourth quarter and full year of 2017.

Tax Reform's Impact on the Economy

Tax Reform's Impact on the Economy

Consumer spending should be more than solid given wage increases.

S&P 500 Will Be Gripped by Classic Investor Euphoria This Year in Surge to 3,000

S&P 500 Will Be Gripped by Classic Investor Euphoria This Year in Surge to 3,000

Is there anything that could derail the stock market's momentum this year? The answer is probably not, suggests Bank of America.

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Here's what you need to know now for Monday, Jan. 22.

Allergan and Energy Stocks Have Big Days

A flurry of high-priced merger-and-acquisition activity explains the move in Allergan.

Dow, S&P 500 and Nasdaq Post New Records as Senate Reaches Deal to End Shutdown

Dow, S&P 500 and Nasdaq Post New Records as Senate Reaches Deal to End Shutdown

Stocks hit fresh records on Monday after a deal is reached to end the three-day government shutdown.

TheStreet Quant Rating: C (Hold)